| ASSET | YEAR | % RETURN |
|---|---|---|
Altimmune (ALT) | 2017 | 29,849,900% |
AquaBounty Technologies (AQB) | 2017 | 977,677.78% |
Precipio (PRPO) | 2017 | 136,418.77% |
Viewbix Inc Common Stock (VBIX) | 2017 | 33,500% |
FingerMotion (FNGR) | 2017 | 8,400% |
HIVE Digital Technologies (HIVE) | 2017 | 3,814.29% |
GT Biopharma (GTBP) | 2017 | 3,769.57% |
GrabAGun Digital (PEW) | 2017 | 2,090.27% |
TSS, Inc Common Stock (TSSI) | 2017 | 1,200% |
Lexinfintech (LX) | 2017 | 1,077.89% |
Orion Digital (ORIO) | 2017 | 925.39% |
Gravity (GRVY) | 2017 | 801.72% |
Riot Platforms (RIOT) | 2017 | 782.18% |
MDxHealth SA ADR (MDXH) | 2017 | 760% |
XOMA Royalty (XOMA) | 2017 | 747.62% |
Cronos (CRON) | 2017 | 592.83% |
AnaptysBio (ANAB) | 2017 | 529.5% |
Madrigal Pharmaceuticals (MDGL) | 2017 | 513.98% |
InMed Pharmaceuticals (INM) | 2017 | 506.61% |
Village Farms International (VFF) | 2017 | 474.78% |
Lexaria Bioscience (LEXX) | 2017 | 458.49% |
Palvella Therapeutics (PVLA) | 2017 | 447.1% |
Esperion Therapeutics (ESPR) | 2017 | 414.38% |
Fennec Pharmaceuticals (FENC) | 2017 | 402% |
Nektar Therapeutics (NKTR) | 2017 | 378.53% |